Ospemifene
Overview
OSPHENA is an estrogen agonist/antagonist.The chemical designation is Z-2-[4-(4-chloro-1,2-diphenylbut-1-enyl)phenoxy]ethano. It is used in the treatment of moderate to severe dyspareunia, a symptom of vulvar and vaginal atrophy, due to menopause.
Categories
- 18 Hormones and other endocrine drugs and contraceptives
Primary Characterstics
Indications
Back to top
Pharmacokinetics
Back to top
Contraindications
Back to top
Back to top
Side Effects
Back to top
Dosage
Ospemifene's dosage details are as follows:
| Dose
|
Single Dose
|
Frequency
|
Route
|
Instructions
|
Adult Dosage
|
| 0 to 60 mg | 30 (30) | As recommended. | PO | for the treatment of moderate to severe Dyspareunia (tablet should be taken with meal.) |
Paedriatic Dosage (20kg)
|
| No data regarding the Paedriatic dosage details of Ospemifene is available. |
Neonatal Dosage (3kg)
|
| No data regarding the neonatal dosage details of Ospemifene is available. |
High Risk Groups
Back to top
Warning / Precautions
Back to top
Storage Conditions
Back to top
Interference in Pathology
Back to top
Brands / Trade Names of
Ospemifene
Back to top
Previous Drug Generic - Next Drug Generic